AKBA
USDAkebia Therapeutics Inc. Common Stock
Цена в режиме реального времени
График цен
Ключевые показатели
Рыночные показатели
Открытие
$2.100
Максимум
$2.145
Минимум
$2.070
Объем
4.47M
Фундаментальные показатели компании
Рыночная капитализация
563.4M
Отрасль
Drug Manufacturers - Specialty & Generic
Страна
United States
Статистические данные торговли
Средний объем
4.04M
Биржа
NCM
Валюта
USD
52-недельный диапазон
Связанные новости
Akebia Therapeutics to Present at Upcoming Investor Conferences
CAMBRIDGE, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (NASDAQ:AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced
HC Wainwright & Co. Maintains Buy on Akebia Therapeutics, Lowers Price Target to $6
HC Wainwright & Co. analyst Matthew Caufield maintains Akebia Therapeutics with a Buy and lowers the price target from $8 to $6.
BTIG Maintains Buy on Akebia Therapeutics, Lowers Price Target to $5
BTIG analyst Julian Harrison maintains Akebia Therapeutics with a Buy and lowers the price target from $10 to $5.
Akebia Therapeutics Provides Update on Vafseo for Non-Dialysis Patients
CAMBRIDGE, Mass., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (NASDAQ:AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced
Связанные акции
SBI
Western Asset Intermediate Muni Fund Inc
SPGI
S&P Global Inc.
HIO
Western Asset High Income Opportunity Fund Inc.
AGM
Federal Agricultural Mortgage Corporation
ESLA
Estrella Immunopharma Inc.
Оставаться в курсе
Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.